RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. EBITDA

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndEBITDA (Million USD)YoY (%)
Jun 30, 20251,884+25.86%
Jun 30, 20241,497+15.40%
Jun 30, 20231,297+11.82%
Jun 30, 20221,160+9.38%
Jun 30, 20211,060+9.95%
Jun 30, 2020965+32.11%
Jun 30, 2019730+10.32%
Jun 30, 2018662+23.02%
Jun 30, 2017538+4.30%
Jun 30, 2016516+6.95%
Jun 30, 2015482+0.78%
Jun 30, 2014479+10.49%
Jun 30, 2013433+13.90%
Jun 30, 2012380+12.66%
Jun 30, 2011338

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)